EHWM
Eads & Heald Wealth Management Portfolio holdings
AUM
$202M
This Quarter Return
+4.84%
1 Year Return
+18.55%
3 Year Return
+74.74%
5 Year Return
+137.36%
10 Year Return
+339.12%
AUM
$202M
AUM Growth
+$202M
(+2.7%)
Cap. Flow
-$999K
Cap. Flow
% of AUM
-0.49%
Top 10 Holdings %
Top 10 Hldgs %
15.11%
Holding
150
New
5
Increased
43
Reduced
91
Closed
6
Top Buys
| 1 |
Cencora
COR
|
$905K |
| 2 |
Caterpillar
CAT
|
$535K |
| 3 |
Globe Life
GL
|
$326K |
| 4 |
Analog Devices
ADI
|
$312K |
| 5 |
Exxon Mobil
XOM
|
$284K |
Top Sells
| 1 |
W.W. Grainger
GWW
|
$472K |
| 2 |
Intel
INTC
|
$464K |
| 3 |
Verisk Analytics
VRSK
|
$285K |
| 4 |
Principal Financial Group
PFG
|
$279K |
| 5 |
3M
MMM
|
$250K |
Sector Composition
| 1 | Healthcare | 18.46% |
| 2 | Technology | 17.35% |
| 3 | Industrials | 15.23% |
| 4 | Consumer Staples | 14.1% |
| 5 | Consumer Discretionary | 12.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Crown Holdings
CCK
$11.6B
| $678K | 0.34% |
8,194
-1,195
| -13% | -$98.9K |
|
102
Mondelez International
MDLZ
$79.5B
| $652K | 0.32% |
9,345
-145
| -2% | -$10.1K |
|
103
Autodesk
ADSK
$67.3B
| $623K | 0.31% |
2,993
+145
| +5% | +$30.2K |
|
104
Mettler-Toledo International
MTD
$26.8B
| $623K | 0.31% |
407
-25
| -6% | -$38.3K |
|
105
PayPal
PYPL
$67.1B
| $594K | 0.29% |
7,828
-528
| -6% | -$40.1K |
|
106
CBRE Group
CBRE
$48.2B
| $589K | 0.29% |
8,085
+1,930
| +31% | +$141K |
|
107
Medtronic
MDT
$119B
| $576K | 0.29% |
7,150
-863
| -11% | -$69.5K |
|
108
Freeport-McMoran
FCX
$63.7B
| $574K | 0.28% |
14,029
-780
| -5% | -$31.9K |
|
109
Amcor
AMCR
$19.9B
| $534K | 0.26% |
46,949
-5,015
| -10% | -$57K |
|
110
Marsh & McLennan
MMC
$101B
| $530K | 0.26% |
3,180
| – | – |
|
111
IBM
IBM
$227B
| $497K | 0.25% |
3,793
-173
| -4% | -$22.7K |
|
112
Pfizer
PFE
$141B
| $490K | 0.24% |
12,000
+4,518
| +60% | +$184K |
|
113
Salesforce
CRM
$245B
| $484K | 0.24% |
2,421
-205
| -8% | -$41K |
|
114
Merck
MRK
$210B
| $482K | 0.24% |
4,526
+44
| +1% | +$4.69K |
|
115
PACCAR
PCAR
$52.5B
| $470K | 0.23% |
6,427
+2,416
| +60% | +$177K |
|
116
AT&T
T
$209B
| $445K | 0.22% |
23,137
-295
| -1% | -$5.67K |
|
117
Charles River Laboratories
CRL
$8.04B
| $425K | 0.21% |
2,105
-746
| -26% | -$151K |
|
118
McCormick & Company Non-Voting
MKC
$18.9B
| $399K | 0.2% |
4,790
-350
| -7% | -$29.2K |
|
119
Morgan Stanley
MS
$240B
| $388K | 0.19% |
4,423
+110
| +3% | +$9.65K |
|
120
Mastercard
MA
$538B
| $370K | 0.18% |
1,017
+107
| +12% | +$38.9K |
|
121
Cigna
CI
$80.3B
| $362K | 0.18% |
1,418
+126
| +10% | +$32.2K |
|
122
ITT
ITT
$13.3B
| $350K | 0.17% |
4,055
-246
| -6% | -$21.2K |
|
123
Citigroup
C
$178B
| $326K | 0.16% |
6,958
-25
| -0.4% | -$1.17K |
|
124
Gilead Sciences
GILD
$140B
| $307K | 0.15% |
3,705
+375
| +11% | +$31.1K |
|
125
ResMed
RMD
$40.2B
| $302K | 0.15% |
1,380
| – | – |
|